| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab8d11472395860339e8767cd6c49342 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-20134 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate |
2012-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8309e05bc540695a8162afbaa32e922e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89e5408b465eb9d08d8b6efed1ee8729
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf979ff68106e5263619835b1642015c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cdbbe109f6846013640334bc190226f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fd93fd69084e85279b42b271acd6ccf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_161d7df1a72d414adc0168d576999c0c |
| publicationDate |
2014-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20140004909-A |
| titleOfInvention |
Recombinant rabies virus and vaccine composition for rabies prevention comprising the same |
| abstract |
The present invention relates to a recombinant rabies virus rERAG333Glu and a vaccine composition for preventing rabies comprising the same. Recombinant rabies virus rERAG333Glu according to the present invention is a recombinant virus strain in which the 333th amino acid of G protein is substituted with glutamic acid, and when produced as a vaccine, the virus content is not only suitable for mass production but also safer than a conventional vaccine. Since it can be used for oral administration, it is effective to solve the problems of the existing rabies virus vaccine and to use it as an effective rabies prevention vaccine. |
| priorityDate |
2012-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |